Discovery Safety Specialist/Toxicologist

Do you have a background in Toxicology, Cell Biology or Pharmacology and a great understanding of Drug Discovery? Are you also an innovative scientist who enjoys working in a team with the common goal deliver novel medicines to patients? Perfect, we have an opening for you at AstraZeneca!

Right now, we are looking for a motivated and passionate individual to join us as a Discovery Safety Specialist. Take the opportunity to play an important part in our Respiratory & Immunology, Neuroscience, Vaccines & Immune Therapies (RINVI) Safety department within the larger global Clinical Pharmacology & Safety Science (CPSS) function. The Safety Science and Discovery teams develop and apply innovative scientific strategies to drive the design and selection of safe medicines for patients suffering from Respiratory and Immunological diseases. The position will be placed at our vibrant R&D site in Gothenburg, Sweden.

As a Discovery Safety Specialist you will combine experience in biology/toxicology/pharmacology, respiratory science and drug discovery to deliver novel medicines to patients and communicate across levels of internal and external stakeholders. Thrive in a place where the brightest and most curious minds seamlessly come together in our inclusive environment.

What you will do:
As true Drug Hunting partner to BioPharma R&D, you will develop innovative solutions and research proposals based on strategic needs versus the discovery project portfolio, to pursue cutting edge science and technologies in order to optimize and influence safety assessment of novel drug targets. You are responsible for the safety strategy in multi-disciplinary drug-hunting preproject/project teams and will lead drug safety teams to influence project decision making with the aim to deliver molecules with the "Right Safety" profile.

We rely on you to contribute to the discovery of innovative treatments for Respiratory and Immunological diseases - and design project-specific in vitro and in vivo strategies to predict, assess and mitigate target- and delivery-related safety risks and execute through internal and external experimental capabilities. You will also engage with world-class experts across our organization to develop, refine and implement experimental strategies to ensure that teams make the right decisions regarding safety risks associated with the project.

Essential in the role:

* PhD in toxicology, cell biology, pharmacology, systems biology or related field, and a strong publication record demonstrating scientific excellence. Relevant on the job experience will also be considered.
* Understanding of the drug discovery and development process based on preferably more than 3 years of experience from the pharmaceutical industry, with an appreciation of disciplines within and outside safety and toxicology, and preferably a track record of successful contributions to progression of drug discovery projects.
* Experience in designing and/or executing safety strategies in drug discovery projects will be considered an advantage.
* Experience with design and execution of in vitro and/or in vivo experiments to determine the effects of therapeutics (e.g. small molecules, monoclonal antibodies, oligonucleotides, peptides, etc) on biological systems.
* Knowledge/experience in the respiratory and/or immunology field will be considered an advantage.

We also believe that the successful candidate is a motivated and innovative scientist, with a team-oriented mindset, who solves problems in a goal-focused way. You should also want to contribute to our open, positive and collaborative working environment.

Why AstraZeneca?
Join a place built on innovation and creativity. Where different views and perspectives are welcomed and valued. Be part of a dedicated Research & Development team. Fuelled by our commitment to help more patients, strengthen our pipeline and grow our area.

So, what's next? If this sounds like your next challenge - apply today!

We look forward to get to know you better. Send in your application as soon as possible, but no later than 5th June, 2022.

For more information please contact Anna Ollerstam, Senior Director, R&I Safety Sciences and Discovery, anna.ollerstam1@astrazeneca.com.

Additional information
Our Gothenburg site: https://www.astrazeneca.com/our-science/gothenburg.html
Life in Gothenburg: https://www.movetogothenburg.com/
Make a move to Global Gothenburg: https://www.youtube.com/watch?v=c-Iqbb4aw38
About BioPharmaceuticals R&D: https://www.astrazeneca.com/r-d.html